ROLE OF TETRAHYDROBIOPTERIN DEFICIENCY IN CARDIOVASCULAR FUNCTION WITH AGING

四氢生物蝶呤缺乏对衰老过程中心血管功能的作用

基本信息

  • 批准号:
    7377876
  • 负责人:
  • 金额:
    $ 0.65万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-04-01 至 2007-03-31
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The age-related decrease in nitric oxide availability constitutes one of the mechanisms by which advancing age adversely affects the cardiovascular function (i.e. endothelial dependent vasodilation and arterial compliance) in humans. There are several potential mechanisms by which nitric oxide production may be reduced with aging. However, current animal and human data sugesst that increased oxidative stress may lead to an absolute and/or relative decrease in BH4, leading to a subsequent decrease in nitric oxide bioavailability. Because advancing age is associated with increased oxidative stress level, it is resonable to hypothesis that the age related changes in cardiovascular function may be, at least in part, due to a decrease in BH4 bioactivity. In contrast, endurance exercise training is associated with a more favorable cardiovascular function and decreased oxydative stress level. Therefore, it is also resonable to hypothesize that the more favorable cardiovascular profile associated with regular exercise may be, at least in part, due to a greater BH4 bioavailability. Consequently, the specific aim of this study is to measure the caridovascular function before and after administering BH4 in young and older sedentary adults and in endurance exercise-trained older adults.
该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者(PI)可能从另一个NIH来源获得了主要资金,因此可以在其他CRISP条目中表示。所列机构为中心,不一定是研究者所在机构。与年龄相关的一氧化氮可用性降低构成了年龄增长对人类心血管功能(即内皮依赖性血管舒张和动脉顺应性)产生不利影响的机制之一。有几个潜在的机制,其中一氧化氮的生产可能会减少与老化。然而,目前的动物和人类数据表明,增加氧化应激可能导致BH 4的绝对和/或相对减少,导致随后的一氧化氮生物利用度降低。由于年龄的增长与氧化应激水平的增加有关,因此可以合理地假设心血管功能的年龄相关变化可能至少部分是由于BH 4生物活性的降低。相比之下,耐力运动训练与更有利的心血管功能和降低氧化应激水平有关。因此,也可以合理地假设,与定期锻炼相关的更有利的心血管特征可能至少部分是由于BH 4的生物利用度更高。因此,本研究的具体目的是测量年轻人和老年人久坐不动的成年人以及接受耐力运动训练的老年人服用BH 4前后的心血管功能。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DOUGLAS R SEALS其他文献

DOUGLAS R SEALS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DOUGLAS R SEALS', 18)}}的其他基金

Passive heat therapy for lowering systolic blood pressure and improving vascular function in mid-life and older adults
被动热疗可降低中年和老年人的收缩压并改善血管功能
  • 批准号:
    10596067
  • 财政年份:
    2022
  • 资助金额:
    $ 0.65万
  • 项目类别:
Targeting cellular senescence to prevent accelerated vascular aging induced by the common chemotherapeutic agent doxorubicin
靶向细胞衰老以防止常见化疗药物阿霉素引起的加速血管老化
  • 批准号:
    10505896
  • 财政年份:
    2022
  • 资助金额:
    $ 0.65万
  • 项目类别:
Passive heat therapy for lowering systolic blood pressure and improving vascular function in mid-life and older adults
被动热疗可降低中年和老年人的收缩压并改善血管功能
  • 批准号:
    10712162
  • 财政年份:
    2022
  • 资助金额:
    $ 0.65万
  • 项目类别:
Targeting cellular senescence to prevent accelerated vascular aging induced by the common chemotherapeutic agent doxorubicin
靶向细胞衰老以防止常见化疗药物阿霉素引起的加速血管老化
  • 批准号:
    10684719
  • 财政年份:
    2022
  • 资助金额:
    $ 0.65万
  • 项目类别:
Passive heat therapy for lowering systolic blood pressure and improving vascular function in mid-life and older adults
被动热疗可降低中年和老年人的收缩压并改善血管功能
  • 批准号:
    10375083
  • 财政年份:
    2022
  • 资助金额:
    $ 0.65万
  • 项目类别:
Mitochondrial-targeted antioxidant supplementation for improving age-related vascular dysfunction in humans
线粒体靶向抗氧化剂补充剂可改善人类与年龄相关的血管功能障碍
  • 批准号:
    10538571
  • 财政年份:
    2021
  • 资助金额:
    $ 0.65万
  • 项目类别:
Inspiratory muscle strength training for lowering blood pressure and improving endothelial function in postmenopausal women: comparison with "standard of care" aerobic exercise
用于降低绝经后妇女血压和改善内皮功能的吸气肌力量训练:与“标准护理”有氧运动的比较
  • 批准号:
    10414050
  • 财政年份:
    2021
  • 资助金额:
    $ 0.65万
  • 项目类别:
Mitochondrial-targeted antioxidant supplementation for improving age-related vascular dysfunction in humans
线粒体靶向抗氧化剂补充剂可改善人类与年龄相关的血管功能障碍
  • 批准号:
    10319609
  • 财政年份:
    2021
  • 资助金额:
    $ 0.65万
  • 项目类别:
Inspiratory muscle strength training for lowering blood pressure and improving endothelial function in postmenopausal women: comparison with "standard of care" aerobic exercise
用于降低绝经后妇女血压和改善内皮功能的吸气肌力量训练:与“标准护理”有氧运动的比较
  • 批准号:
    10178631
  • 财政年份:
    2021
  • 资助金额:
    $ 0.65万
  • 项目类别:
Inspiratory muscle strength training for lowering blood pressure and improving endothelial function in postmenopausal women: comparison with "standard of care" aerobic exercise
用于降低绝经后妇女血压和改善内皮功能的吸气肌力量训练:与“标准护理”有氧运动的比较
  • 批准号:
    10576933
  • 财政年份:
    2021
  • 资助金额:
    $ 0.65万
  • 项目类别:

相似海外基金

Probing Role of Tetrahydrobiopterin in Cerebral Palsy by Using Transgenic Rabbits
利用转基因兔探讨四氢生物蝶呤在脑瘫中的作用
  • 批准号:
    10530589
  • 财政年份:
    2020
  • 资助金额:
    $ 0.65万
  • 项目类别:
Development for the prevention of obesity and diabetes by regulation of brown adipose tissue volume using tetrahydrobiopterin
通过使用四氢生物蝶呤调节棕色脂肪组织体积来预防肥胖和糖尿病的开发
  • 批准号:
    20K08903
  • 财政年份:
    2020
  • 资助金额:
    $ 0.65万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Probing Role of Tetrahydrobiopterin in Cerebral Palsy by Using Transgenic Rabbits
利用转基因兔探讨四氢生物蝶呤在脑瘫中的作用
  • 批准号:
    10312139
  • 财政年份:
    2020
  • 资助金额:
    $ 0.65万
  • 项目类别:
Tetrahydrobiopterin in sepsis associated encephalopathy and its consideration as a therapeutic target.
四氢生物蝶呤在脓毒症相关脑病中的作用及其作为治疗靶点的考虑。
  • 批准号:
    19K09438
  • 财政年份:
    2019
  • 资助金额:
    $ 0.65万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mutual adjustment of autonomic nervous system and nitric oxide biosynthesis via tetrahydrobiopterin
四氢生物蝶呤对自主神经系统与一氧化氮生物合成的相互调节
  • 批准号:
    19K07331
  • 财政年份:
    2019
  • 资助金额:
    $ 0.65万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study of the dynamics of tetrahydrobiopterin in sepsis and the potentiality of BH4 as therapeutic target.
四氢生物蝶呤在脓毒症中的动力学研究以及 BH4 作为治疗靶点的潜力。
  • 批准号:
    18K08894
  • 财政年份:
    2018
  • 资助金额:
    $ 0.65万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Tetrahydrobiopterin prevents coronary artery malformations induced by pregestational diabetes
四氢生物蝶呤预防妊娠前糖尿病引起的冠状动脉畸形
  • 批准号:
    368473
  • 财政年份:
    2017
  • 资助金额:
    $ 0.65万
  • 项目类别:
Role of tetrahydrobiopterin in differentiation and proliferation of brown adipose tissue and application of transplantation therapy
四氢生物蝶呤在棕色脂肪组织分化、增殖中的作用及移植治疗的应用
  • 批准号:
    17K09826
  • 财政年份:
    2017
  • 资助金额:
    $ 0.65万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Tetrahydrobiopterin in Fetal Hypoxic Brain Injury
四氢生物蝶呤在胎儿缺氧性脑损伤中的作用
  • 批准号:
    9304605
  • 财政年份:
    2016
  • 资助金额:
    $ 0.65万
  • 项目类别:
Tetrahydrobiopterin-deficiency causes hypertension with fluctuation, bradycardia and priapism.
四氢生物蝶呤缺乏会引起波动性高血压、心动过缓和阴茎异常勃起。
  • 批准号:
    16K08561
  • 财政年份:
    2016
  • 资助金额:
    $ 0.65万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了